TreeWAS – Variant ID: rs11051970

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E66.9 Obesity, unspecified	0.000	0.919	0.081
S72.40 Fracture of lower end of femur (closed)	0.031	0.969	0.000
E66 Obesity	0.000	0.978	0.022
E03.9 Hypothyroidism, unspecified	0.000	0.982	0.018
E66.0 Obesity due to excess calories	0.000	0.983	0.017
E66.2 Extreme obesity with alveolar hypoventilation	0.000	0.984	0.016
E66.1 Drug-induced obesity	0.000	0.984	0.016
S72.4 Fracture of lower end of femur	0.016	0.984	0.000
C34.3 Lower lobe, bronchus or lung	0.014	0.986	0.000
C34 Malignant neoplasm of bronchus and lung	0.013	0.987	0.000
C16.9 Stomach, unspecified	0.000	0.987	0.013
C34.9 Bronchus or lung, unspecified	0.012	0.988	0.000
S72.41 Fracture of lower end of femur (open)	0.012	0.988	0.000
C34.0 Main bronchus	0.012	0.988	0.000
N62 Hypertrophy of breast	0.011	0.989	0.000
C16 Malignant neoplasm of stomach	0.000	0.989	0.011
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)	0.011	0.989	0.000
C34.2 Middle lobe, bronchus or lung	0.010	0.990	0.000
C16.0 Cardia	0.000	0.990	0.010
C16.5 Lesser curvature of stomach, unspecified	0.000	0.991	0.009
C34.1 Upper lobe, bronchus or lung	0.009	0.991	0.000
C34.8 Overlapping lesion of bronchus and lung	0.009	0.991	0.000
C16.6 Greater curvature of stomach, unspecified	0.000	0.991	0.009
C16.1 Fundus of stomach	0.000	0.992	0.008
C16.2 Body of stomach	0.000	0.992	0.008
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.008	0.992	0.000
C16.8 Overlapping lesion of stomach	0.000	0.992	0.008
C16.4 Pylorus	0.000	0.992	0.008
E65-E68 Obesity and other hyperalimentation	0.000	0.992	0.008
E03 Other hypothyroidism	0.000	0.992	0.008
C16.3 Pyloric antrum	0.000	0.993	0.007
Z37.2 Twins, both liveborn	0.000	0.993	0.007
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.007	0.993	0.000
M23.80 Other internal derangements of knee (Multiple sites)	0.006	0.994	0.000
K26.7 Chronic without haemorrhage or perforation	0.006	0.994	0.000
E03.8 Other specified hypothyroidism	0.000	0.994	0.006
E67 Other hyperalimentation	0.000	0.994	0.006
E68 Sequelae of hyperalimentation	0.000	0.994	0.006
E03.1 Congenital hypothyroidism without goitre	0.000	0.994	0.006
E03.5 Myxoedema coma	0.000	0.994	0.006
E03.4 Atrophy of thyroid (acquired)	0.000	0.994	0.006
E03.3 Postinfectious hypothyroidism	0.000	0.994	0.006
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.994	0.006
Y44.2 Anticoagulants	0.006	0.994	0.000
M23.8 Other internal derangements of knee	0.006	0.994	0.000
M13.90 Arthritis, unspecified (Multiple sites)	0.000	0.994	0.006
T78.1 Other adverse food reactions, not elsewhere classified	0.005	0.995	0.000
I86.8 Varicose veins of other specified sites	0.005	0.995	0.000
S72 Fracture of femur	0.005	0.995	0.000
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.005	0.995	0.000
Z80.4 Family history of malignant neoplasm of genital organs	0.005	0.995	0.000
Y44 Agents primarily affecting blood constituents	0.005	0.995	0.000
S72.8 Fractures of other parts of femur	0.005	0.995	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.005	0.995	0.000
E65 Localised adiposity	0.000	0.995	0.005
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.995	0.004
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.005	0.995	0.000
S72.80 Fractures of other parts of femur (closed)	0.005	0.995	0.000
M23.84 Other internal derangements of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.005	0.995	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.005	0.995	0.000
Y41.0 Sulphonamides	0.004	0.995	0.000
E67.8 Other specified hyperalimentation	0.000	0.996	0.004
E67.3 Hypervitaminosis D	0.000	0.996	0.004
E67.2 Megavitamin-B6 syndrome	0.000	0.996	0.004
E67.1 Hypercarotenaemia	0.000	0.996	0.004
E67.0 Hypervitaminosis A	0.000	0.996	0.004
Y52.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
I98.2 Oesophageal varices in diseases classified elsewhere	0.004	0.996	0.000
M23.87 Other internal derangements of knee (Capsular ligament)	0.004	0.996	0.000
M23.85 Other internal derangements of knee (Posterior horn of lateral meniscus)	0.004	0.996	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.004	0.996	0.000
Y54.5 Other diuretics	0.004	0.996	0.000
M23.82 Other internal derangements of knee (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.004	0.996	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
Y57.9 Drug or medicament, unspecified	0.004	0.996	0.000
Z49.1 Extracorporeal dialysis	0.004	0.996	0.000
T78 Adverse effects, not elsewhere classified	0.004	0.996	0.000
S72.3 Fracture of shaft of femur	0.004	0.996	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.004	0.996	0.000
Y44.5 Thrombolytic drugs	0.004	0.996	0.000
S72.7 Multiple fractures of femur	0.004	0.996	0.000
Y54.3 Benzothiadiazine derivatives	0.004	0.996	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.004	0.996	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.004	0.996	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
Y57 Other and unspecified drugs and medicaments	0.004	0.996	0.000
I86 Varicose veins of other sites	0.004	0.996	0.000
Y54.8 Agents affecting uric acid metabolism	0.004	0.996	0.000
Y54.4 Loop [high-ceiling] diuretics	0.004	0.996	0.000
S72.2 Subtrochanteric fracture	0.004	0.996	0.000
Y41.1 Antimycobacterial drugs	0.004	0.996	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.004	0.996	0.000
Y44.7 Plasma substitutes	0.004	0.996	0.000
Y44.6 Natural blood and blood products	0.004	0.996	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.004	0.996	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.004	0.996	0.000
Y46.6 Other and unspecified antiepileptics	0.004	0.996	0.000
T78.8 Other adverse effects, not elsewhere classified	0.004	0.996	0.000
K27 Peptic ulcer, site unspecified	0.004	0.996	0.000
S72.81 Fractures of other parts of femur (open)	0.004	0.996	0.000
I86.1 Scrotal varices	0.004	0.996	0.000
S72.9 Fracture of femur, part unspecified	0.004	0.996	0.000
M23.83 Other internal derangements of knee (Medial collateral ligament or Other and unspecified medial meniscus)	0.004	0.996	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
Y41.4 Anthelminthics	0.004	0.996	0.000
Y41.3 Other antiprotozoal drugs	0.004	0.996	0.000
R27.8 Other and unspecified lack of coordination	0.000	0.996	0.004
Y52.1 Calcium-channel blockers	0.004	0.996	0.000
B07 Viral warts	0.004	0.996	0.000
I86.4 Gastric varices	0.004	0.996	0.000
Y52 Agents primarily affecting the cardiovascular system	0.004	0.996	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.003	0.996	0.000
Y54.9 Mineral salts, not elsewhere classified	0.003	0.996	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.996	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.996	0.000
Y54.0 Mineralocorticoids	0.003	0.996	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.996	0.000
Y57.6 Other diagnostic agents	0.003	0.997	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
Y45.8 Other analgesics and antipyretics	0.003	0.997	0.000
T78.2 Anaphylactic shock, unspecified	0.003	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
M23.86 Other internal derangements of knee (Other and unspecified lateral meniscus)	0.003	0.997	0.000
T75.4 Effects of electric current	0.003	0.997	0.000
K27.4 Chronic or unspecified with haemorrhage	0.003	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.997	0.000
R19.8 Other specified symptoms and signs involving the digestive system and abdomen	0.003	0.997	0.000
K27.3 Acute without haemorrhage or perforation	0.003	0.997	0.000
S72.30 Fracture of shaft of femur (closed)	0.003	0.997	0.000
S72.31 Fracture of shaft of femur (open)	0.003	0.997	0.000
T78.9 Adverse effect, unspecified	0.003	0.997	0.000
T78.0 Anaphylactic shock due to adverse food reaction	0.003	0.997	0.000
C33 Malignant neoplasm of trachea	0.003	0.997	0.000
T78.3 Angioneurotic oedema	0.003	0.997	0.000
Y46.4 Iminostilbenes	0.003	0.997	0.000
Y46.2 Hydantoin derivatives	0.003	0.997	0.000
Y54.7 Agents affecting calcification	0.003	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.997	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.003	0.997	0.000
S72.71 Multiple fractures of femur (open)	0.003	0.997	0.000
S72.70 Multiple fractures of femur (closed)	0.003	0.997	0.000
S72.0 Fracture of neck of femur	0.003	0.997	0.000
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
C31 Malignant neoplasm of accessory sinuses	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
C37 Malignant neoplasm of thymus	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
I86.0 Sublingual varices	0.003	0.997	0.000
Y41.5 Antiviral drugs	0.003	0.997	0.000
Y53.4 Other laxatives	0.003	0.997	0.000
S72.21 Subtrochanteric fracture (open)	0.003	0.997	0.000
I86.3 Vulval varices	0.003	0.997	0.000
Y45.4 Antirheumatics	0.003	0.997	0.000
T78.4 Allergy, unspecified	0.003	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.003	0.997	0.000
K27.6 Chronic or unspecified with both haemorrhage and perforation	0.003	0.997	0.000
K27.5 Chronic or unspecified with perforation	0.003	0.997	0.000
K27.2 Acute with both haemorrhage and perforation	0.003	0.997	0.000
K27.1 Acute with perforation	0.003	0.997	0.000
K27.0 Acute with haemorrhage	0.003	0.997	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
S72.91 Fracture of femur, part unspecified (open)	0.003	0.997	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.997	0.003
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
G45.4 Transient global amnesia	0.000	0.997	0.003
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
Y53.7 Emetics	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.003	0.997	0.000
Y53.5 Digestants	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.003	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
S72.20 Subtrochanteric fracture (closed)	0.003	0.997	0.000
Y50.9 Central nervous system stimulant, unspecified	0.003	0.997	0.000
Y50.8 Other central nervous system stimulants	0.003	0.997	0.000
Y50.1 Opioid receptor antagonists	0.003	0.997	0.000
Y50.0 Analeptics	0.003	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
I86.2 Pelvic varices	0.003	0.997	0.000
S72.1 Pertrochanteric fracture	0.003	0.997	0.000
Y49.2 Other and unspecified antidepressants	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
K27.7 Chronic without haemorrhage or perforation	0.002	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
S72.90 Fracture of femur, part unspecified (closed)	0.002	0.997	0.000
Y57.8 Other drugs and medicaments	0.002	0.997	0.000
C38.4 Pleura	0.002	0.997	0.000
Y45.1 Salicylates	0.003	0.997	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.997	0.000
S82.21 Fracture of shaft of tibia (open)	0.003	0.997	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.002	0.997	0.000
C38.3 Mediastinum, part unspecified	0.002	0.997	0.000
C38.2 Posterior mediastinum	0.002	0.997	0.000
C38.1 Anterior mediastinum	0.002	0.997	0.000
C38.0 Heart	0.002	0.997	0.000
M88.9 Paget's disease of bone, unspecified	0.002	0.997	0.000
T75 Effects of other external causes	0.002	0.997	0.000
S72.01 Fracture of neck of femur (open)	0.002	0.997	0.000
C39.9 Ill-defined sites within the respiratory system	0.002	0.997	0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.002	0.997	0.000
C39.0 Upper respiratory tract, part unspecified	0.002	0.997	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.997	0.000
Y47.4 Bromine compounds	0.002	0.997	0.000
Y47.3 Paraldehyde	0.002	0.997	0.000
Y47.2 Chloral derivatives	0.002	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.997	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.997	0.000
Y56.9 Topical agent, unspecified	0.002	0.997	0.000
Y56.8 Other topical agents	0.002	0.997	0.000
Y56.7 Dental drugs, topically applied	0.002	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.997	0.000
Y56.2 Local astringents and local detergents	0.002	0.997	0.000
Y56.1 Antipruritics	0.002	0.997	0.000
C31.9 Accessory sinus, unspecified	0.002	0.997	0.000
C31.8 Overlapping lesion of accessory sinuses	0.002	0.997	0.000
C31.3 Sphenoidal sinus	0.002	0.997	0.000
C31.2 Frontal sinus	0.002	0.997	0.000
C31.1 Ethmoidal sinus	0.002	0.997	0.000
M54.96 Dorsalgia, unspecified (Lumbar region)	0.000	0.997	0.003
C31.0 Maxillary sinus	0.002	0.997	0.000
Y45.5 4-Aminophenol derivatives	0.002	0.997	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.997	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.997	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.997	0.000
Y51.0 Anticholinesterase agents	0.002	0.997	0.000
Z92.8 Personal history of other medical treatment	0.000	0.997	0.003
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Z36.1 Antenatal screening for raised alphafetoprotein level	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
C30.1 Middle ear	0.002	0.998	0.000
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
S82.20 Fracture of shaft of tibia (closed)	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
R26.3 Immobility	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
M93.9 Osteochondropathy, unspecified	0.000	0.998	0.002
I98 Other disorders of circulatory system in diseases classified elsewhere	0.002	0.998	0.000
C30.0 Nasal cavity	0.002	0.998	0.000
D22.4 Melanocytic naevi of scalp and neck	0.002	0.998	0.000
C32 Malignant neoplasm of larynx	0.002	0.998	0.000
S72.11 Pertrochanteric fracture (open)	0.002	0.998	0.000
R27 Other lack of coordination	0.000	0.998	0.002
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
R27.0 Ataxia, unspecified	0.000	0.998	0.002
R17 Unspecified jaundice	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
M88.98 Paget's disease of bone, unspecified (Other)	0.002	0.998	0.000
M88.97 Paget's disease of bone, unspecified (Ankle and foot)	0.002	0.998	0.000
M88.96 Paget's disease of bone, unspecified (Lower leg)	0.002	0.998	0.000
M88.94 Paget's disease of bone, unspecified (Hand)	0.002	0.998	0.000
M88.93 Paget's disease of bone, unspecified (Forearm)	0.002	0.998	0.000
M88.92 Paget's disease of bone, unspecified (Upper arm)	0.002	0.998	0.000
M88.91 Paget's disease of bone, unspecified (Shoulder region)	0.002	0.998	0.000
T75.8 Other specified effects of external causes	0.002	0.998	0.000
T75.3 Motion sickness	0.002	0.998	0.000
T75.2 Effects of vibration	0.002	0.998	0.000
T75.1 Drowning and nonfatal submersion	0.002	0.998	0.000
T75.0 Effects of lightning	0.002	0.998	0.000
M77.12 Lateral epicondylitis (Upper arm)	0.002	0.998	0.000
J92.9 Pleural plaque without asbestos	0.000	0.998	0.002
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
M65.34 Trigger finger-Hand	0.000	0.998	0.002
Z75.5 Holiday relief care	0.002	0.998	0.000
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.002	0.998	0.000
M88.99 Paget's disease of bone, unspecified (Site unspecified)	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
Z36.9 Antenatal screening, unspecified	0.002	0.998	0.000
S82.2 Fracture of shaft of tibia	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
V80.9 Rider or occupant injured in other and unspecified transport accidents	0.002	0.998	0.000
M88.95 Paget's disease of bone, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
I98.8 Other specified disorders of circulatory system in diseases classified elsewhere	0.002	0.998	0.000
I98.1 Cardiovascular disorders in other infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
I98.0 Cardiovascular syphilis	0.002	0.998	0.000
Z58.1 Exposure to air pollution	0.002	0.998	0.000
I98.3 Oesophageal varices with bleeding in diseases classified elsewhere	0.002	0.998	0.000
C32.8 Overlapping lesion of larynx	0.002	0.998	0.000
C32.3 Laryngeal cartilage	0.002	0.998	0.000
C32.2 Subglottis	0.002	0.998	0.000
O36.8 Maternal care for other specified foetal problems	0.002	0.998	0.000
T66-T78 Other and unspecified effects of external causes	0.002	0.998	0.000
N64.1 Fat necrosis of breast	0.000	0.998	0.002
S01.9 Open wound of head, part unspecified	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
M54.99 Dorsalgia, unspecified (Site unspecified)	0.000	0.998	0.002
C32.1 Supraglottis	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.001	0.998	0.000
Y48.1 Parenteral anaesthetics	0.001	0.998	0.000
Y48.0 Inhaled anaesthetics	0.001	0.998	0.000
Y40 Systemic antibiotics	0.002	0.998	0.000
Z36 Antenatal screening	0.002	0.998	0.000
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.000	0.998	0.002
M46.9 Inflammatory spondylopathy, unspecified	0.002	0.998	0.000
M54.9 Dorsalgia, unspecified	0.000	0.998	0.002
M35.1 Other overlap syndromes	0.000	0.998	0.002
O21.1 Hyperemesis gravidarum with metabolic disturbance	0.000	0.998	0.002
L05.9 Pilonidal cyst without abscess	0.000	0.998	0.002
X23.9 Unspecified place	0.002	0.998	0.000
Y85.0 Sequelae of motor-vehicle accident	0.000	0.998	0.002
E66.8 Other obesity	0.000	0.998	0.002
Y48.4 Anaesthetic, unspecified	0.001	0.998	0.000
Z36.8 Other antenatal screening	0.002	0.998	0.000
Z31.0 Tuboplasty or vasoplasty after previous sterilisation	0.000	0.998	0.002
M25.06 Haemarthrosis (Lower leg)	0.000	0.998	0.002
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.002	0.998	0.000
M54.98 Dorsalgia, unspecified (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.002	0.998	0.000
I74.5 Embolism and thrombosis of iliac artery	0.002	0.998	0.000
M54.90 Dorsalgia, unspecified (Multiple sites in spine)	0.000	0.998	0.002
Z96.2 Presence of otological and audiological implants	0.002	0.998	0.000
Y85.9 Sequelae of other and unspecified transport accidents	0.000	0.998	0.002
O21.0 Mild hyperemesis gravidarum	0.000	0.998	0.002
Y40.3 Macrolides	0.002	0.998	0.000
M54.95 Dorsalgia, unspecified (Thoracolumbar region)	0.000	0.998	0.002
A87.9 Viral meningitis, unspecified	0.000	0.998	0.002
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.998	0.002
N89.5 Stricture and atresia of vagina	0.000	0.998	0.002
T74 Maltreatment syndromes	0.001	0.998	0.000
T73 Effects of other deprivation	0.001	0.998	0.000
T69 Other effects of reduced temperature	0.001	0.998	0.000
T67 Effects of heat and light	0.001	0.998	0.000
G83.2 Monoplegia of upper limb	0.000	0.998	0.002
E34.9 Endocrine disorder, unspecified	0.000	0.998	0.002
N48.4 Impotence of organic origin	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.001	0.998	0.000
Y40.2 Chloramphenicol group	0.001	0.998	0.000
Z36.5 Antenatal screening for isoimmunisation	0.001	0.998	0.000
M67.2 Synovial hypertrophy, not elsewhere classified	0.000	0.998	0.002
Y48.2 Other and unspecified general anaesthetics	0.001	0.998	0.001
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.001	0.998	0.000
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.001	0.998	0.000
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.001	0.998	0.000
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.001	0.998	0.000
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.001	0.998	0.000
M54.93 Dorsalgia, unspecified (Cervicothoracic region)	0.000	0.998	0.001
M54.91 Dorsalgia, unspecified (Occipito-atlanto-axial region)	0.000	0.998	0.001
D59.9 Acquired haemolytic anaemia, unspecified	0.001	0.998	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.002	0.998	0.000
S72.00 Fracture of neck of femur (closed)	0.002	0.998	0.000
C53.9 Cervix uteri, unspecified	0.002	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.001	0.998	0.000
Y40.6 Rifamycins	0.001	0.998	0.000
Y85 Sequelae of transport accidents	0.000	0.998	0.002
G83.4 Cauda equina syndrome	0.000	0.998	0.001
N99.3 Prolapse of vaginal vault after hysterectomy	0.000	0.998	0.002
Y40.8 Other systemic antibiotics	0.001	0.998	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.001	0.998	0.000
C32.0 Glottis	0.001	0.998	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.001	0.998	0.000
Z43.1 Attention to gastrostomy	0.000	0.998	0.001
T70 Effects of air pressure and water pressure	0.001	0.998	0.000
M54.97 Dorsalgia, unspecified (Lumbosacral region)	0.000	0.999	0.001
C83.0 Small cell (diffuse)	0.001	0.999	0.000
I74.0 Embolism and thrombosis of abdominal aorta	0.001	0.999	0.000
Y40.5 Aminoglycosides	0.001	0.999	0.000
Y40.4 Tetracyclines	0.001	0.999	0.000
Y48.3 Local anaesthetics	0.001	0.999	0.001
O21 Excessive vomiting in pregnancy	0.000	0.999	0.001
E61.1 Iron deficiency	0.000	0.999	0.001
T71 Asphyxiation	0.001	0.999	0.000
M54.94 Dorsalgia, unspecified (Thoracic region)	0.000	0.999	0.001
M85.89 Other specified disorders of bone density and structure (Site unspecified)	0.000	0.999	0.001
S06.80 Other intracranial injuries (without open intracranial wound)	0.000	0.999	0.001
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.001	0.999	0.000
G45.0 Vertebro-basilar artery syndrome	0.000	0.999	0.001
J38.3 Other diseases of vocal cords	0.001	0.999	0.000
O21.8 Other vomiting complicating pregnancy	0.000	0.999	0.001
T67.9 Effects of heat and light, unspecified	0.001	0.999	0.000
T67.8 Other effects of heat and light	0.001	0.999	0.000
T67.7 Heat oedema	0.001	0.999	0.000
T67.6 Heat fatigue, transient	0.001	0.999	0.000
T67.5 Heat exhaustion, unspecified	0.001	0.999	0.000
T67.4 Heat exhaustion due to salt depletion	0.001	0.999	0.000
T67.3 Heat exhaustion, anhydrotic	0.001	0.999	0.000
T67.2 Heat cramp	0.001	0.999	0.000
T67.1 Heat syncope	0.001	0.999	0.000
T67.0 Heatstroke and sunstroke	0.001	0.999	0.000
T69.9 Effect of reduced temperature, unspecified	0.001	0.999	0.000
T69.8 Other specified effects of reduced temperature	0.001	0.999	0.000
T69.1 Chilblains	0.001	0.999	0.000
T69.0 Immersion hand and foot	0.001	0.999	0.000
T73.9 Effect of deprivation, unspecified	0.001	0.999	0.000
T73.8 Other effects of deprivation	0.001	0.999	0.000
T73.3 Exhaustion due to excessive exertion	0.001	0.999	0.000
T73.2 Exhaustion due to exposure	0.001	0.999	0.000
T73.1 Effects of thirst	0.001	0.999	0.000
T73.0 Effects of hunger	0.001	0.999	0.000
T74.9 Maltreatment syndrome, unspecified	0.001	0.999	0.000
T74.8 Other maltreatment syndromes	0.001	0.999	0.000
T74.3 Psychological abuse	0.001	0.999	0.000
T74.2 Sexual abuse	0.001	0.999	0.000
T74.1 Physical abuse	0.001	0.999	0.000
T74.0 Neglect or abandonment	0.001	0.999	0.000
M25.54 Pain in joint (Hand)	0.000	0.999	0.001
Y87.1 Sequelae of assault	0.000	0.999	0.001
Z75.2 Other waiting period for investigation and treatment	0.001	0.999	0.000
G45 Transient cerebral ischaemic attacks and related syndromes	0.000	0.999	0.001
M25.74 Osteophyte (Hand)	0.001	0.999	0.000
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.000	0.999	0.001
K25.7 Chronic without haemorrhage or perforation	0.001	0.999	0.000
X23.0 Home	0.001	0.999	0.000
T66 Unspecified effects of radiation	0.001	0.999	0.000
C32.9 Larynx, unspecified	0.001	0.999	0.000
R09.1 Pleurisy	0.000	0.999	0.001
Z44.3 Fitting and adjustment of external breast prosthesis	0.001	0.999	0.000
I85.0 Oesophageal varices with bleeding	0.001	0.999	0.000
O21.9 Vomiting of pregnancy, unspecified	0.000	0.999	0.001
H33.1 Retinoschisis and retinal cysts	0.000	0.999	0.001
N18.2 Chronic kidney disease, stage 2	0.000	0.999	0.001
O21.2 Late vomiting of pregnancy	0.000	0.999	0.001
T70.9 Effect of air pressure and water pressure, unspecified	0.001	0.999	0.000
T70.8 Other effects of air pressure and water pressure	0.001	0.999	0.000
T70.4 Effects of high-pressure fluids	0.001	0.999	0.000
T70.2 Other and unspecified effects of high altitude	0.001	0.999	0.000
T70.1 Sinus barotrauma	0.001	0.999	0.000
T70.0 Otitic barotrauma	0.001	0.999	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.001	0.999	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.999	0.001
G83.9 Paralytic syndrome, unspecified	0.000	0.999	0.001
I31.9 Disease of pericardium, unspecified	0.000	0.999	0.001
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.000	0.999	0.001
J35.0 Chronic tonsillitis	0.000	0.999	0.001
O30.0 Twin pregnancy	0.000	0.999	0.001
X23 Contact with hornets, wasps and bees	0.001	0.999	0.000
E34.8 Other specified endocrine disorders	0.000	0.999	0.001
J37.0 Chronic laryngitis	0.001	0.999	0.000
M54.92 Dorsalgia, unspecified (Cervical region)	0.000	0.999	0.001
M81.40 Drug-induced osteoporosis (Multiple sites)	0.001	0.999	0.000
G45.8 Other transient cerebral ischaemic attacks and related syndromes	0.000	0.999	0.001
G45.1 Carotid artery syndrome (hemispheric)	0.000	0.999	0.001
H35.8 Other specified retinal disorders	0.000	0.999	0.001
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.001	0.999	0.000
G45.2 Multiple and bilateral precerebral artery syndromes	0.000	0.999	0.001
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.001	0.999	0.000
M19.93 Arthrosis, unspecified (Forearm)	0.001	0.999	0.000
C83.7 Burkitt's tumour	0.001	0.999	0.000
H57.9 Disorder of eye and adnexa, unspecified	0.001	0.999	0.000
L73.2 Hidradenitis suppurativa	0.000	0.999	0.001
Z75.0 Medical services not available in home	0.001	0.999	0.000
M93 Other osteochondropathies	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations